Kirkland advised Teva, while Baker McKenzie and Herzog, Fox & Neeman advised the underwriters on the offering. Teva Pharmaceutical Industries Limited executed a $5 billion (equivalent) (upsized...
This content is for Standard 1 Year members only. LoginJoin Now